Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post-hoc analysis through 64 weeks from reSURFACE 1 trial
| Image |  |
|---|---|
| Description | scientific article published on 26 September 2020 |
| Author/s |
author: Jacek Szepietowski Kristian Reich José Manuel Carrascosa Mark G. Lebwohl |
| Publication date | September 26, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |